Cargando…
False-Positive Liquid Biopsy Assays Secondary to Overlapping Aberrant Methylation from Non-Cancer Disease States
INTRODUCTION: Liquid biopsies are increasingly being adopted in the care of patients with cancer. Not only in patients with metastatic disease but the utility is also being recognized in earlier phases of the journey of a patient with cancer. More recently, methylated platforms are offering another...
Autores principales: | Lutfi, Areeb, Afghan, Maaz Khan, Swed, Brandon, Kasi, Pashtoon Murtaza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697744/ http://dx.doi.org/10.1159/000535174 |
Ejemplares similares
-
Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy
por: Lutfi, Areeb, et al.
Publicado: (2023) -
Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies
por: Kasi, Pashtoon Murtaza
Publicado: (2022) -
Types of Liquid Biopsies: Understanding the Different Lenses Through Which They Can Detect Cancer
por: Kasi, Pashtoon Murtaza
Publicado: (2023) -
Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies
por: Malkawi, Walla, et al.
Publicado: (2023) -
Favorable Outcomes in FGFR Fusion-Positive Cholangiocarcinomas and Evolution on Treatment Noted on Circulating Tumor DNA Liquid Biopsies
por: Kasi, Pashtoon Murtaza
Publicado: (2020)